/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Compass Health Files Land-Use Application, Receives Additional Funding for Redevelopment to Address Regional Behavioral Health and Homelessness Issues
Transformative Broadway Campus Redevelopment will provide full
continuum of permanent supportive housing, behavioral healthcare and
integrated medical care in downtown Everett
EVERETT, Wash.–(BUSINESS WIRE)–This week Compass Health filed a proposed land-use application for phase
one of its Broadway Campus Redevelopment, which will expand capacity to
address regional homelessness and behavioral health issues, including
mental health and substance abuse.
The organization also received a $1.5 million investment from New
York-based Primary Care Development Corporation (PCDC) to support
ongoing design and early development work for the multi-phase project.
PCDC supports impactful innovation in healthcare integration throughout
the United States.
The milestones mark key steps in realizing Compass Health’s vision to
transform the look and function of the 3300 block of downtown Everett,
providing much-needed infrastructure to deliver innovative,
evidence-based models of care that meet urgent community needs.
“Lawmakers, community and business leaders, and behavioral health
providers agree that modernizing our state’s behavioral health system
through community-based care is the most effective solution to address
the complex issues of homelessness and behavioral health,” said Tom
Sebastian, CEO of Compass Health. “We are working ahead of the curve to
expand our capacity at a meaningful scale, enabling us to improve the
lives of more people and support an efficient and effective regional
response to these issues.”
Phase one of the Broadway Campus Redevelopment, set to break ground in
fall 2019, will add 82 new units of permanent supportive housing,
doubling Compass Health’s housing capacity in Snohomish County.
Sited at the corner of Lombard Avenue and 33rd Street, the
47,193-square-foot, five-story multi-family building will integrate
affordable housing with treatment and support services for people with
chronic behavioral health issues. The ground floor will include more
than 10,000 square feet for programs to support residents, along with
other mental health and homelessness services, including peer support,
homeless outreach and housing stabilization.
Funding for the $26 million phase one facility comes from a combination
of public and private sources, including significant support from
Snohomish County, the Washington State Department of Commerce, the State
Housing Finance Commission and Federal Home Loan Bank of Des Moines.
The affordable housing project will be operated under the Housing First
model for Supportive Housing, which aligns with the City of Everett’s
Safe Streets initiative to help individuals transition out of
homelessness by providing low-barrier access to housing while they
receive the other services and support they need. The building’s design
– featuring four floors of residential wood frame construction over
ground floor common area amenities that connect visually with the street
frontage – also fits the Metro Everett Sub-Area planning vision and
aesthetic for intensified development.
The development team includes Lotus Development Partners (Development
Manager); Environmental Works (Architect) and BNBuilders (General
Contractor). Other consultants include Harmsen (Civil Engineer); Swensen
Say Faget (Structural); Sider & Byers (Mechanical and Electrical); and
Thomas Rengstorf (Landscape Design).
As part of its Broadway Campus Redevelopment, Compass Health is planning
a second state-of-the-art facility for behavioral health prevention and
early intervention to replace its 70-year-old Bailey Center building on
Broadway Avenue. This portion of the project has received nearly $4
million in Washington State Department of Commerce Behavioral Health
funding, and the Washington State Legislature’s proposed budget
dedicates another $3.5 million from its Building Communities Fund. This
multi-phase project will require additional public resources and private
funding through a dedicated capital campaign.
Phase three of the campus redevelopment, still in the early design
stages, is projected to focus on integrating behavioral health services
with a primary healthcare clinic and pharmacy, in addition to supporting
other services.
Overall, project leaders emphasized the project’s timeliness, necessity
to address critical community challenges and singular assets as key
contributors to its future success.
“Homelessness and behavioral health issues are two of the most
formidable challenges affecting our region – and we must use every tool
at our disposal to address them,” Sebastian said. “Our Broadway Campus
Redevelopment draws on synergies that just can’t be replicated: a fully
owned but underutilized downtown block, an organization with the scale
to make a regional impact, and highly skilled professionals implementing
evidence- and community-based services that work. We’re looking forward
to making this infrastructure a reality.”
About Compass Health:
Compass Health is Northwest Washington’s behavioral healthcare leader.
The organization integrates behavioral health and medical care services
to support clients and communities when and where they are needed.
Building on a century of experience, Compass Health is forging new,
nationally recognized models of care that bring together highly skilled
mental health professionals, primary care providers, peer counselors and
others to treat the whole person. From comprehensive mental health
treatment to crisis intervention, children’s services and community
education, Compass Health serves people of all ages throughout Island,
San Juan, Skagit, Snohomish and Whatcom counties.
Learn more: www.compasshealth.org
Contacts
Annie Alley
206.466.2713
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE3 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace